Stockscreener 앱 받기
3.18
0.00%
0.00
시간 외 거래:
3.18
전일 마감가:
$3.18
열려 있는:
$3.15
하루 거래량:
175.32K
Relative Volume:
0.61
시가총액:
$104.68M
수익:
-
순이익/손실:
$-12.48M
주가수익비율:
-8.1538
EPS:
-0.39
순현금흐름:
$-7.93M
1주 성능:
+1.92%
1개월 성능:
-33.61%
6개월 성능:
-1.55%
1년 성능:
+34.18%
1일 변동 폭
$3.105
$3.25
1주일 범위
$3.06
$3.25
52주 변동 폭
$2.07
$5.4566
Anixa Biosciences Inc Stock (ANIX) Company Profile
명칭
Anixa Biosciences Inc
전화
408-708-9808
주소
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
ANIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
3.18 | 104.68M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 개시 | Maxim Group | Buy |
| 2022-12-23 | 개시 | Chardan Capital Markets | Buy |
| 2021-04-12 | 개시 | H.C. Wainwright | Buy |
Anixa Biosciences Inc 주식(ANIX)의 최신 뉴스
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (ANIX) Expected to Announce Quarterly Earnings on Friday - MarketBeat
Anixa announces transfer of IND for breast cancer vaccine from Cleveland Clinic - MSN
Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest - MarketBeat
Anixa Biosciences director Titterton buys $8,820 in common stock - MSN
Anixa Biosciences (STU:CY71) EV-to-OCF : -12.38 (As of Dec. 28, 2025) - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Anixa Biosciences (FRA:CY71) EV-to-OCF : -12.43 (As of Dec. 22, 2025) - GuruFocus
Why analysts upgrade Anixa Biosciences Inc. stock2025 Risk Factors & Precise Buy Zone Identification - Улправда
Can Anixa Biosciences Inc. stock attract ESG capital inflowsMarket Sentiment Review & Low Drawdown Trading Techniques - Улправда
Is Anixa Biosciences Inc. stock gaining market shareEarnings Recap Report & AI Enhanced Trading Signals - Улправда
Why retail investors pile into Anixa Biosciences Inc. stock2025 Market Overview & Safe Capital Preservation Plans - Улправда
Is Anixa Biosciences Inc. (CY71) stock a buy for dividend portfolios2025 Macro Impact & Fast Exit Strategy with Risk Control - DonanımHaber
ANIX: Phase 1 Breast Cancer Vaccine Success Paves Way for Program Advancement - Smartkarma
Will Anixa Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Selloffs & Capital Protection Trade Alerts - DonanımHaber
Gap Down: Is Anixa Biosciences Inc CY71 stock cheap by valuation metricsNew Guidance & Target Return Focused Stock Picks - moha.gov.vn
What is the fair value of Anixa Biosciences Inc. stock now2025 EndofYear Setup & Fast Gain Swing Alerts - Улправда
How strong is Anixa Biosciences Inc. stock balance sheetWeekly Profit Summary & Growth Focused Stock Pick Reports - Улправда
Aug Action: Why Anixa Biosciences Inc stock could be next big winnerMarket Movers & Fast Momentum Entry Tips - moha.gov.vn
Anixa Biosciences Inc (ANIX) director reports 16,000 share option exercise - Stock Titan
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic - Investing.com Australia
Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo Finance
ANIX: Breast cancer vaccine phase I showed 75% robust immune response and strong safety profile - TradingView — Track All Markets
Anixa Biosciences falls on phase 1 data for breast cancer vaccine - MSN
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 - WV News
Cleveland Clinic transfers breast cancer vaccine IND to Anixa - marketscreener.com
Anixa Biosciences (ANIX) Advances Breast Cancer Vaccine Developm - GuruFocus
Anixa Biosciences Announces Transfer of IND for Breast Cancer Va - GuruFocus
Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic By Investing.com - Investing.com South Africa
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic - Nasdaq
D. Boral Capital Maintains Anixa Biosciences (ANIX) Buy Recommendation - Nasdaq
Anixa Biosciences (ANIX) Shares Drop 21% After Phase 1 Vaccine D - GuruFocus
Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital - MarketBeat
ANIX: D. Boral Capital Maintains Buy Rating with $10 Price Targe - GuruFocus
Anixa Biosciences Reports Positive Phase 1 Trial Results - TipRanks
Anixa Biosciences Inc Announces Positive Phase 1 Data for Breast Cancer Vaccine - TradingView — Track All Markets
Anixa Biosciences Says Breast Cancer Vaccine Candidate Meets Key Endpoints in Phase 1 Trial - marketscreener.com
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why - Benzinga
Anixa Biosciences Announces Positive Phase 1 Data for Investigat - GuruFocus
Anixa Biosciences (ANIX) Presents Promising Phase 1 Breast Cance - GuruFocus
Anixa Biosciences (NASDAQ: ANIX) presents final Phase 1 breast cancer vaccine data - Stock Titan
Anixa’s breast cancer vaccine shows positive Phase 1 results - Investing.com
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants - WV News
Cleveland Clinic Presents Final Results of Phase 1 Clinical Trial of Preventive Breast Cancer Vaccine Study - Cleveland Clinic Newsroom
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Anixa Biosciences (NASDAQ: ANIX) sets Dec. 15 talk on Phase 1 breast cancer vaccine - Stock Titan
Anixa Biosciences (NASDAQ: ANIX) unveils final Phase 1 breast cancer vaccine results at 2025 SABCS - Stock Titan
Will Anixa Biosciences Inc. (CY71) stock beat Nasdaq index returns2025 Risk Factors & Real-Time Stock Entry Alerts - Newser
Why Anixa Biosciences Inc. (CY71) stock is trending on social mediaPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Will Anixa Biosciences Inc. stock see PE expansionWeekly Trading Summary & Risk Controlled Stock Pick Alerts - Newser
Is Anixa Biosciences Inc. stock undervalued vs historical averagesJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Anixa Biosciences Inc (ANIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):